Prognostic value of cytogenetic findings in adults with acute myeloid leukemiaMROZEK, Krzysztof; HEINONEN, Kristiina; BLOOMFIELD, Clara D et al.International journal of hematology. 2000, Vol 72, Num 3, pp 261-271, issn 0925-5710Article

Cytogenetics in acute leukemiaMROZEK, Krzysztof; HEEREMA, Nyla A; BLOOMFIELD, Clara D et al.Blood reviews. 2004, Vol 18, Num 2, pp 115-136, issn 0268-960X, 22 p.Article

Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?MARCUCCI, Guido; CALIGIURI, Michael A; BLOOMFIELD, Clara D et al.European journal of haematology. 2003, Vol 71, Num 3, pp 143-154, issn 0902-4441, 12 p.Article

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics : Myeloid diseaseMARCUCCI, Guido; MROZEK, Krzysztof; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2005, Vol 12, Num 1, pp 68-75, issn 1065-6251, 8 p.Article

Molecular and clinical advances in core binding factor primary acute myeloid leukemia : A paradigm for translational research in malignant hematologyMARCUCCI, Guido; CALIGIURI, Michael A; BLOOMFIELD, Clara D et al.Cancer investigation. 2000, Vol 18, Num 8, pp 768-780, issn 0735-7907Article

Influence of new molecular prognostic markers in patients with karyotypically normal acute myeloid leukemia : recent advancesMROZEK, Krzysztof; DÖHNER, Hartmut; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2007, Vol 14, Num 2, pp 106-114, issn 1065-6251, 9 p.Article

Acute Myeloid LeukemiaBLOOMFIELD, Clara D; MARCUCCI, Guido; DÖHNER, Konstanze et al.Seminars in oncology. 2008, Vol 35, Num 4, issn 0093-7754, 139 p.Serial Issue

Clinical importance of cytogenetics in acute myeloid leukaemiaMROZEK, Krzysztof; HEINONEN, Kristiina; BLOOMFIELD, Clara D et al.Baillière's best practice & research. Clinical haematology. 2001, Vol 14, Num 1, pp 19-47, issn 1521-6926Article

Acute leukemia: recent advancesBLOOMFIELD, Clara D; HERZIG, Geoffrey P; CALIGIURI, Michael A et al.Seminars in oncology. 1997, Vol 24, Num 1, issn 0093-7754, 153 p.Serial Issue

Molecular signatures in acute myeloid leukemiaMROZEK, Krzysztof; RADMACHER, Michael D; BLOOMFIELD, Clara D et al.Current opinion in hematology. 2009, Vol 16, Num 2, pp 64-69, issn 1065-6251, 6 p.Article

Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations : a concise reviewBALDUS, Claudia D; MROZEK, Krzysztof; MARCUCCI, Guido et al.British journal of haematology. 2007, Vol 137, Num 5, pp 387-400, issn 0007-1048, 14 p.Article

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia in First or Subsequent Remission : Weighing Prognostic Markers Predicting Relapse and Risk Factors for Non-relapse MortalityMEIJER, Ellen; CORNELISSEN, Jan J.Seminars in oncology. 2008, Vol 35, Num 4, pp 449-457, issn 0093-7754, 9 p.Article

Cancer and leukemia Group B leukemia correlative science committee : Major accomplishments and future directionsBLOOMFIELD, Clara D; MROZEK, Krzysztof; CALIGIURI, Michael A et al.Clinical cancer research. 2006, Vol 12, Num 11, issn 1078-0432, 3564s-3571s, 2Article

Molecular biology of acute lymphocytic leukemiaTHANDLA, S; APLAN, P. D.Seminars in oncology. 1997, Vol 24, Num 1, pp 45-56, issn 0093-7754Article

Allogeneic hematopoietic stem cell transplantation for acute leukemiaAPPELBAUM, F. R.Seminars in oncology. 1997, Vol 24, Num 1, pp 114-123, issn 0093-7754Article

Cytogenetic, Molecular Genetic, and Clinical Characteristics of Acute Myeloid Leukemia With a Complex KaryotypeMROZEK, Krzysztof.Seminars in oncology. 2008, Vol 35, Num 4, pp 365-377, issn 0093-7754, 13 p.Article

New Drugs in Acute Myeloid LeukemiaESTEY, Elihu.Seminars in oncology. 2008, Vol 35, Num 4, pp 439-448, issn 0093-7754, 10 p.Article

BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics : Prognostic implicationsBALDUS, Claudia D; THIEDE, Christian; SOUCEK, Silke et al.Journal of clinical oncology. 2006, Vol 24, Num 5, pp 790-797, issn 0732-183X, 8 p.Article

The prognostic and functional role of microRNAs in acute myeloid leukemiaMARCUCCI, Guido; MROZEK, Krzysztof; RADMACHER, Michael D et al.Blood. 2011, Vol 117, Num 4, pp 1121-1129, issn 0006-4971, 9 p.Article

Prognostic Implications of Gene Mutations in Acute Myeloid Leukemia With Normal CytogeneticsGAIDZIK, Verena; DÖHNER, Konstanze.Seminars in oncology. 2008, Vol 35, Num 4, pp 346-355, issn 0093-7754, 10 p.Article

Gene Expression With Prognostic Implications in Cytogenetically Normal Acute Myeloid LeukemiaBALDUS, Claudia D; BULLINGER, Lars.Seminars in oncology. 2008, Vol 35, Num 4, pp 356-364, issn 0093-7754, 9 p.Article

Core Binding Factor Acute Myeloid LeukemiaPASCHKA, Peter.Seminars in oncology. 2008, Vol 35, Num 4, pp 410-417, issn 0093-7754, 8 p.Article

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics : are we ready for a prognostically prioritized molecular classification?MROZEK, Krzysztof; MARCUCCI, Guido; PASCHKA, Peter et al.Blood. 2007, Vol 109, Num 2, pp 431-448, issn 0006-4971, 18 p.Article

The treatment of adult acute myeloid leukemiaBISHOP, J. F.Seminars in oncology. 1997, Vol 24, Num 1, pp 57-69, issn 0093-7754Article

A phase II study of the oral VEGF receptor tyrosine kinase inhibitor vatalanib (PTK787/ZK222584) in myelodysplastic syndrome: Cancer and Leukemia Group B study 10105 (Alliance)GUPTA, Pankaj; MULKEY, Flora; LARSON, Richard A et al.Investigational new drugs. 2013, Vol 31, Num 5, pp 1311-1320, issn 0167-6997, 10 p.Article